Figure 3.
ROC curves for miR-107 in (A) EGFR exon 19 deletion (19DEL), (B) EGFR p.L858R mutation, and (C) EGFR mutation-positive (MUT[+]) patients with NSCLC versus EGFR wild-type (WT) patients.
ROC curves for miR-107 in (A) EGFR exon 19 deletion (19DEL), (B) EGFR p.L858R mutation, and (C) EGFR mutation-positive (MUT[+]) patients with NSCLC versus EGFR wild-type (WT) patients.